文献速递生殖医学

严重急性呼吸综合征冠状病毒2逆转录聚合酶链反应检测方法的验证:评估人类精液病毒污染的必要条件

Validation of a SARS-CoV-2 RT-PCR assay: a requirement to evaluate viral contamination in human semen.
PubMed 文献 · Reprod Biomed Online · 2022-09-06

本研究为质量改进研究,前瞻性验证在人类精液及精子组分中直接检测严重急性呼吸综合征冠状病毒2的逆转录聚合酶链反应方法。该方法在精浆和精子组分中均具备可重复性、可再现性,检测限为0.33个基因组拷贝/微升,定量限为1个拷贝/微升,且不受精液质量、精子数量或冷冻保护剂影响。

要点

  • 验证的逆转录聚合酶链反应方法可在精浆和精子组分中准确可靠地筛查严重急性呼吸综合征冠状病毒2。
  • 检测限为0.33个基因组拷贝/微升,定量限为1个拷贝/微升。
  • 方法有效性不受精液质量、精子数量或冷冻保护剂影响。

核心结论

  • 该验证的逆转录聚合酶链反应方法为精浆和精子组分中的严重急性呼吸综合征冠状病毒2提供了准确可靠的筛查。
  • 该方法对于确保冷冻保存过程中免受病毒污染至关重要。

研究设计与样本

  • 本研究为质量改进研究,旨在对男性精液中严重急性呼吸综合征冠状病毒2的检测进行前瞻性验证。
  • 样本来自在克莱蒙费朗大学医院生殖医学中心因不孕症接受常规精液分析的患者,为辅助生殖技术治疗采集的剩余精液。
  • 精浆和精子组分通过密度梯度离心分离并冷冻保存,阳性样本使用灭活严重急性呼吸综合征冠状病毒2颗粒标准品制备。

主要发现

  • 在精浆和精子组分中,该检测方法均具备可重复性和可再现性。
  • 检测限为0.33个严重急性呼吸综合征冠状病毒2基因组拷贝/微升,定量限为1个基因组拷贝/微升。
  • 方法有效性不受精液质量(精子参数正常或异常)、精子数量或用于冷冻精子的冷冻保护剂培养基影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is it possible to validate an accurate and reliable method for direct detection of SARS-CoV-2 by reverse transcription polymerase chain reaction (RT-PCR) in human semen fractions? DESIGN: This qualitative improvement study aimed to provide a prospective validation of SARS-CoV-2 detection in male semen. The SARS-CoV-2 genome was detected by multiplex real-time RT-PCR on patient samples that underwent routine semen analyses for infertility at the Center for Reproductive Medicine at the University Hospital of Clermont-Ferrand. Samples comprised surplus semen collected for treatment with assisted reproductive technology. Seminal fluid and spermatozoa fractions were isolated with density gradient centrifugation and cryopreserved. Positive samples were prepared with a standard of inactivated SARS-CoV-2 particles. RESULTS: The analytical method was validated in both seminal fluid and spermatozoa fractions. In both semen fractions, the assay was repeatable, reproducible and showed high sensitivity with a limit of detection of 0.33 SARS-CoV-2 genome copies/µl. The limit of quantification was 1 copy of the SARS-CoV-2 genome/µl. The method was effective regardless of semen quality (normal and altered sperm parameters), number of spermatozoa or the cryoprotectant media used to freeze spermatozoa. CONCLUSION: This validated RT-PCR assay provided accurate and reliable screening of SARS-CoV-2 in seminal fluid and spermatozoa fractions. This method is essential to ensure protection against viral contamination in the cryobanking process.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Chabrolles H, Pons-Rejraji H, Chaput L, et al. Validation of a SARS-CoV-2 RT-PCR assay: a requirement to evaluate viral contamination in human semen. Reprod Biomed Online. 2022. PMID: 36270932. doi:10.1016/j.rbmo.2022.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。